UNICA IRIS Institutional Research Information System

PRETTA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 37.114
NA - Nord America 3.968
AS - Asia 2.637
SA - Sud America 363
Continente sconosciuto - Info sul continente non disponibili 314
AF - Africa 68
OC - Oceania 7
Totale 44.471
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 36.132
US - Stati Uniti d'America 3.806
SG - Singapore 1.041
CN - Cina 716
BR - Brasile 270
VN - Vietnam 267
SE - Svezia 240
DE - Germania 157
FR - Francia 121
BD - Bangladesh 118
FI - Finlandia 108
HK - Hong Kong 106
GB - Regno Unito 103
IN - India 102
CA - Canada 90
NL - Olanda 79
KR - Corea 47
MX - Messico 38
TR - Turchia 32
IQ - Iraq 30
JP - Giappone 26
PL - Polonia 25
AT - Austria 24
AR - Argentina 23
ZA - Sudafrica 23
ES - Italia 22
IE - Irlanda 20
PH - Filippine 19
CO - Colombia 18
EC - Ecuador 17
AE - Emirati Arabi Uniti 16
PK - Pakistan 15
IR - Iran 14
UZ - Uzbekistan 14
VE - Venezuela 14
ID - Indonesia 13
RU - Federazione Russa 13
BE - Belgio 12
SA - Arabia Saudita 12
UA - Ucraina 11
MA - Marocco 10
CR - Costa Rica 8
LT - Lituania 8
AU - Australia 7
CL - Cile 7
KE - Kenya 7
TH - Thailandia 7
GR - Grecia 6
JM - Giamaica 6
TN - Tunisia 6
IL - Israele 5
NP - Nepal 5
PE - Perù 5
BO - Bolivia 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
EG - Egitto 4
KG - Kirghizistan 4
PY - Paraguay 4
AZ - Azerbaigian 3
BB - Barbados 3
BZ - Belize 3
DZ - Algeria 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
BH - Bahrain 2
DM - Dominica 2
GA - Gabon 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
MN - Mongolia 2
MU - Mauritius 2
MY - Malesia 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
JO - Giordania 1
KH - Cambogia 1
Totale 44.148
Salva come PNG Salva come JPEG
Città #
Cagliari 33.733
Uta 1.832
Singapore 638
Dallas 548
Ashburn 488
San Jose 352
Council Bluffs 201
Boardman 179
Beijing 142
Los Angeles 141
Nyköping 104
Hong Kong 99
Santa Clara 95
New York 93
Chandler 89
Ho Chi Minh City 88
Fairfield 85
Hefei 77
Helsinki 71
The Dalles 66
Rome 63
Columbus 60
Hanoi 54
Milan 53
Amsterdam 52
Shanghai 52
Orem 49
Lauterbourg 45
Seoul 45
Houston 40
Seattle 40
Florence 39
Frankfurt am Main 39
Munich 35
Montreal 33
Nuremberg 33
Wilmington 33
Boston 32
São Paulo 31
Buffalo 30
Redondo Beach 30
Cambridge 28
Chicago 28
Guangzhou 28
Chennai 26
Woodbridge 26
Pune 22
Lappeenranta 21
London 20
Toronto 20
Dublin 19
San Diego 19
Warsaw 19
Manchester 18
Scandicci 18
Stockholm 18
Phoenix 17
Denver 16
Shenzhen 16
Tokyo 16
Turku 15
Düsseldorf 14
Johannesburg 14
Mexico City 14
Poplar 14
Tashkent 14
Atlanta 13
Brooklyn 13
Charlotte 13
Elk Grove Village 13
Turin 13
San Francisco 12
Selargius 12
Rio de Janeiro 11
Baghdad 10
Haiphong 10
Jacksonville 10
Mumbai 10
Naples 10
Paris 10
Salt Lake City 10
Vienna 10
Da Nang 9
Dubai 9
Istanbul 9
Newark 9
Tianjin 9
Wuhan 9
Brussels 8
Cleveland 8
Dong Ket 8
Hangzhou 8
New Delhi 8
Quito 8
Roubaix 8
Ankara 7
Medellín 7
Riyadh 7
Washington 7
Zhengzhou 7
Totale 40.814
Salva come PNG Salva come JPEG
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 3.249
Molecular-biology-driven treatment for metastatic colorectal cancer 2.780
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.384
New therapeutic targets in pancreatic cancer 1.656
Immunotherapy and Cancer: The Multi-Omics Perspective 1.630
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.548
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.372
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.228
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.203
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 1.098
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 1.059
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 998
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 985
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 968
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 953
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 943
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 907
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib 904
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 877
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 782
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 773
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 763
Uncovering key targets of success for immunotherapy in pancreatic cancer 730
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 683
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 683
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 673
BRCA-mutant pancreatic ductal adenocarcinoma 626
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 617
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 613
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 602
Immune Checkpoint Inhibitors in the Treatment of HCC 599
Primary adrenal insufficiency induced by immune checkpoint inhibitors: Biological, clinical, and radiological aspects 556
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 497
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 467
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 445
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects 394
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 357
Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas 354
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 352
Artificial Intelligence Models for the Detection of Microsatellite Instability from Whole-Slide Imaging of Colorectal Cancer 329
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 312
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 303
CD44: A New Prognostic Marker in Colorectal Cancer? 279
Early taxane exposure and neurotoxicity in breast cancer patients 234
A new prognostic score for biliary tract cancer: a multicenter experience 233
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 220
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 214
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 213
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 206
Cancer-associated fibroblasts (CAFs) and plaque-associated fibroblasts (PAFs): Unraveling the cellular crossroads of atherosclerosis and cancer 196
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 195
Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions 194
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors 193
Medical management of malignant bowel obstruction: our center experience 191
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 179
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 148
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 144
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 133
Exercise Prescription in Cardio-Oncology 132
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 127
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 124
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 121
The impact of the fetal exposome as a predictor of cancer risk in childhood and adulthood. Aberrant epigenetic events occurring during gestation: May they trigger fetal programming of cancer risk later in life? 120
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 116
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 112
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 111
The role of metastasectomy in patients with early onset metastatic colorectal cancer 109
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon 95
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial 83
Predicability of PD-L1 expression in cancer cells based solely on H&E-stained sections 79
Treatment compliance in early-stage anal cancer 44
Development and validation of the gastric risk immuno-progression score (GRIPS) in advanced gastric and gastroesophageal junction adenocarcinoma treated with first-line chemotherapy plus nivolumab: Results from the ORACLE study 42
Generative intelligence in precision oncology: Priorities in informatics engineering, pathology and oncology 34
Artificial intelligence in histological profiling of hepatocellular carcinoma: state of the art 33
L1cam expression in the peritumoral stromal cells of the microenvironment of colorectal cancer: a new target for oncologists? 30
The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited Disease 29
886eP The impact of RAS and BRAF mutations on immunotherapy outcomes in MSI-H/dMMR metastatic colorectal cancer patients: A systematic review and meta-analysis 27
Integrating Artificial Intelligence into Breast Cancer Histopathology: Toward Improved Diagnosis and Prognosis 26
Correction : Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions (International Journal of Molecular Sciences, (2025), 26, 15, (7619), 10.3390/ijms26157619) 26
Abstract 28: Prognostic value of baseline and early changes of circulating cell-free (cf)DNA in the neoadjuvant setting of early stage colon cancer (CC) 24
Estrogen Receptor-Low Positive (ER-Low) Breast Cancer: A Unique Clinical and Pathological Entity 22
What is the role of physical exercise after surgery for gastric cancer? A scoping review 22
L1CAM expression identifies different colorectal tumor subgroups 22
Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selection 21
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 20
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine–nab-paclitaxel failure: a propensity score-matched analysis 19
null 19
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial 18
Distinct molecular and clinical aggressiveness in very early-onset metastatic colorectal cancer: survival and genomic divergence between patients aged 30-39 versus 40-49 years 17
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel 17
Real-world efficacy of first-line chemotherapy plus nivolumab in gastric and GEJ adenocarcinoma patients: The ORACLE study 17
Colorectal cancer: Biology and pathology 17
Aspirin in Colorectal Cancer Care: Who to Treat, When, and Why 16
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials 16
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer 16
Abstract 4653: Platelet to lymphocyte ratio and platelet count: new frontiers as prognostic factors in metastatic colorectal cancer patients receiving anti-angiogenic drugs 15
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer 15
Interpretable artificial intelligence-driven selection of doublet chemotherapy regimens as second-line treatment in patients with advanced pancreatic cancer 15
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study 13
Ultra–early-onset metastatic colorectal cancer (<35 years): RAS-driven, APC/TP53-depleted, TMB-low molecular features in a real-world analysis of 2,392 patients 13
Totale 44.418
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.133
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.828 0 0 24 97 119 135 96 187 170 229 334 437
2022/20235.037 400 643 563 372 376 438 226 391 428 528 441 231
2023/20245.556 261 184 185 280 429 859 960 424 371 351 576 676
2024/202517.561 5.035 5.672 1.555 1.659 786 1.105 805 104 197 185 149 309
2025/20267.775 499 410 791 646 535 509 1.497 810 473 653 569 383
2026/2027923 260 476 187 0 0 0 0 0 0 0 0 0
Totale 44.471